News
WVE
3.470
-1.98%
-0.070
Wave Life Sciences: FDA-Aligned AATD Registrational Path, Obesity Combination Study, and GSK Milestones Underscore Buy Rating and $42 Price Target
TipRanks · 1d ago
Weekly Report: what happened at WVE last week (0928-1002)?
Weekly Report · 3d ago
Weekly Buzz: EW, ABBV, MIRM Score FDA Wins, AZN, NVO Strike Deals; LLY, KOD Report Data
NASDAQ · 6d ago
Analysts Offer Insights on Healthcare Companies: Cigna (CI), Wave Life Sciences (WVE) and Regeneron (REGN)
TipRanks · 6d ago
Analysts Are Bullish on Top Healthcare Stocks: Johnson & Johnson (JNJ), Wave Life Sciences (WVE)
TipRanks · 6d ago
Analysts Offer Insights on Healthcare Companies: Wave Life Sciences (WVE), Liquidia Technologies (LQDA) and Abbott Laboratories (ABT)
TipRanks · 6d ago
Wave Life Sciences Price Target Announced at $10.00/Share by Ladenburg Thalmann
Dow Jones · 10/01 16:26
Midday Fly By: Micron earnings beat, MSG Sports approves Rangers spinoff
TipRanks · 10/01 16:01
Wave Life jumps as FDA backs registrational plans for AATD therapy
Seeking Alpha · 10/01 14:52
Wave Life Sciences announces FDA feedback supports pathway for WVE-006
TipRanks · 10/01 11:40
Wave Life Sciences Plans For Two-Year Registrational Trial For WVE-006 To Treat Alpha-1 Antitrypsin Deficiency
Benzinga · 10/01 11:31
Wave Life Sciences initiated with a Buy at Ladenburg
TipRanks · 10/01 10:50
Analysts Offer Insights on Healthcare Companies: Q32 Bio (QTTB) and Wave Life Sciences (WVE)
TipRanks · 09/30 17:20
This Dow Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
Benzinga · 09/30 12:54
Wave to receive $12M milestone as GSK picks liver candidate
Seeking Alpha · 09/30 12:18
Wave Life Science Advance Liver-Focused SiRNA Program With GSK; Stock Up
NASDAQ · 09/30 12:05
Wave Life Sciences Announces GSK’s Selection of siRNA program to Transition to GSK for Further Development
Barchart · 09/30 06:30
This PepsiCo Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
Benzinga · 09/29 14:40
This PepsiCo Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday
Benzinga · 09/28 17:47
Weekly Report: what happened at WVE last week (0921-0925)?
Weekly Report · 09/28 09:12
More
Webull provides a variety of real-time WVE stock news. You can receive the latest news about Wave Life Scienc through multiple platforms. This information may help you make smarter investment decisions.
About WVE
Wave Life Sciences Ltd. is a biotechnology company focused on unlocking the broad potential of ribonucleic acid (RNA) medicines to transform human health. The Company's RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and common disorders. Its toolkit of RNA-targeting modalities includes editing, splicing, RNA interference and antisense silencing, providing Wave with unmatched capabilities for designing and sustainably delivering candidates that optimally address disease biology. The Company's diversified pipeline includes clinical programs in alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease, as well as several preclinical programs utilizing the Company's broad RNA therapeutics toolkit. Its programs include WVE-006, SERPINA1 (AATD); WVE-007 (GalNAc), INHBE (Obesity); WVE-N531, Exon 53 (DMD), and WVE-003, mHTT (HD).